TrialThe European respiratory journal2023

Long-term inhaled treprostinil for pulmonary hypertension due to interstitial lung disease: INCREASE open-label extension study.

Aaron Waxman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.